Table 3.
Tissue contents of DA, DOPAC, and HVA (represents in ng/g of tissue) in the frontal cortex and striatum of mice brain were measured by HPLC, and the ratios of (DOPAC + HVA)/DA were analyzed after DSP-4, pCPA, and MPTP administration respectively.
Treatments | Frontal cortex | Striatum | ||||||
---|---|---|---|---|---|---|---|---|
DA | DOPAC | HVA | (DOPAC+HVA)/DA | DA | DOPAC | HVA | (DOPAC+HVA)/DA | |
Saline (n = 12) | 521.7 ± 45.8 | 32.8 ± 2.6 | 48.9 ± 3.1 | 0.15 ± 0.06 | 7,020 ± 551.4 | 617.7 ± 56.8 | 997.8 ± 78.2 | 0.23 ± 0.04 |
DSP-4 (n = 10) | 506.4 ± 27.9 | 30.3 ± 4.3 | 43.1 ± 5.3 | 0.14 ± 0.05 | 6,742 ± 600.7 | 553.8 ± 58.4 | 889.9 ± 96.3 | 0.21 ± 0.08 |
pCPA (n = 12) | 531.5 ± 28.4 | 34.4 ± 2.9 | 56.5 ± 6.1 | 0.17 ± 0.05 | 6,574 ± 391.6 | 698.2 ± 67.3 | 941.4 ± 88.5 | 0.25 ± 0.08 |
MPTP (n = 9) | 496.9 ± 44.1 | 36.8 ± 5.1 | 69.5 ± 5.6 | 0.21 ± 0.07 | 1,494 ± 155.8*** | 347.9 ± 25.7*** | 543.5 ± 63.1*** | 0.59 ± 0.12** |
DSP-4/pCPA (n = 11) | 507.5 ± 44.6 | 28.9 ± 3.5 | 43.6 ± 4.4 | 0.14 ± 0.06 | 7,175 ± 532.4 | 603.7 ± 67.6 | 897.8 ± 74.4 | 0.21 ± 0.04 |
DSP-4/MPTP (n = 9) | 473.9 ± 20.5 | 34.1 ± 3.6 | 52.1 ± 3.7 | 0.18 ± 0.06 | 847.7 ± 71.0***## | 189.1 ± 23.1*** | 235.6 ± 21.3*** | 0.51 ± 0.11** |
pCPA/MPTP (n = 10) | 474.8 ± 28.9 | 31.7 ± 2.9 | 42.6 ± 3.2 | 0.15 ± 0.04 | 977.2 ± 105.6***# | 213.3 ± 24.4*** | 231.2 ± 18.4*** | 0.45 ± 0.12* |
DSP-4/pCPA/MPTP (n = 11) | 127.1 ± 15.9*** | 10.7 ± 1.2*** | 24.6 ± 2.1** | 0.28 ± 0.08** | 620.4 ± 81.3***### | 165.4 ± 19.9*** | 193.2 ± 15.7*** | 0.57 ± 0.14** |
All values are expressed as mean ± S.E.M.
p < 0.05,
p < 0.01,
p < 0.001 in comparison with saline group;
p < 0.05,
p < 0.01,
p < 0.001 in comparison with MPTP group.